Trexquant Investment’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Trexquant Investment’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-61,460	Closed	-$1.32M	–	1879
2022 Q4	$1.32M	Buy	61,460 +26,582	+76%	+$567K	0.04%	548
2022 Q3	$626K	Sell	34,878 -38,337	-52%	-$503K	0.02%	719
2022 Q2	$704K	Buy	+73,215	New	+$919K	0.03%	655
2021 Q3	–	Sell	-25,954	Closed	-$164K	–	1597
2021 Q2	$164K	Buy	+25,954	New	+$167K	0.01%	948
2016 Q4	–	Sell	-13,680	Closed	-$631K	–	1187
2016 Q3	$631K	Sell	13,680 -16,056	-54%	-$905K	0.14%	239
2016 Q2	$1.52M	Buy	+29,736	New	+$1.48M	0.2%	145
2015 Q4	–	Sell	-19,900	Closed	-$806K	–	1335
2015 Q3	$806K	Buy	+19,900	New	+$1.05M	0.07%	509

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Trexquant Investment's ISEE Position: Q1 2023 in Review

Trexquant Investment sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 61,460 shares — an estimated $1.32M sold.

Trexquant Investment first reported a position in ISEE in Q3 2015 and held it in 7 quarters. The position peaked at $1.52M in Q2 2016. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Trexquant Investment reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Trexquant Investment sold 61,460 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $1.32M.
Trexquant Investment first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 7 quarters.
Trexquant Investment's IVERIC bio, Inc. Common Stock position peaked at $1.52M in Q2 2016.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Trexquant Investment's 13F filing for Q1 2023, filed 15 May 2023.